| 52-Week High | 0.2000 |
|---|---|
| Fibonacci 50% | 0.1123 |
| Fibonacci 38.2% | 0.0915 |
| Last Price | 0.0900 |
| 52-Week Low | 0.0245 |
Where can I buy Emerald Bioscience shares?
Shares of EMBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Emerald Bioscience's stock price today?
Is emerald Bioscience (EMBR) a good buy with a negative PE ratio?
Only 5.58% of the stock of Emerald Bioscience is held by institutions. The P/E ratio of Emerald Bioscience is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What does Emerald Bioscience do?
Sign-up to receive the latest news and ratings for Emerald Bioscience and its competitors with MarketBeat's FREE daily newsletter. Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide.
Where can I buy shares of Embi?
Shares of EMBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Skye Bioscience A Good Investment?
If you are looking for stocks with good return, Skye Bioscience Inc can be a profitable investment option. Skye Bioscience Inc quote is equal to 0.0388 USD at 2022-07-16. Based on our forecasts, a long-term increase is expected, the "EMBI" stock price prognosis for 2027-03-10 is 11.661 USD.
Is Harvard Bioscience a buy?
The 3 analysts offering 12-month price forecasts for Harvard Bioscience Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +155.75% increase from the last price of 3.91.
Who are Emerald Bioscience's key executives?
Emerald Bioscience's management team includes the following people: Mr. Punit S. Dhillon B.A. , BA, Exec. Chairman & CEO (Age 40, Pay $65k) Mr....
Who are some of Emerald Bioscience's key competitors?
Some companies that are related to Emerald Bioscience include Neoleukin Therapeutics (NLTX) , Societal CDMO (SCTL) , Elite Pharmaceuticals (ELTP...
What other stocks do shareholders of Emerald Bioscience own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Bioscience investors own include Fulcrum Therapeut...
What is Emerald Bioscience's stock symbol?
Emerald Bioscience trades on the OTCMKTS under the ticker symbol "EMBI."
How do I buy shares of Emerald Bioscience?
Shares of EMBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Emerald Bioscience's stock price today?
One share of EMBI stock can currently be purchased for approximately $0.04.
How much money does Emerald Bioscience make?
Emerald Bioscience has a market capitalization of $10.67 million.
How many employees does Emerald Bioscience have?
Emerald Bioscience employs 4 workers across the globe.
What is Emerald Bioscience's official website?
The official website for Emerald Bioscience is www.emeraldbio.life .
What is Emerald Bioscience?
What is Emerald Pharmaceuticals?
04, 2020 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald”), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced that it has raised approximately $7.0 million in a registered offering of an aggregate of 116,666,668 units, each consisting of (i) one share of common stock (or common stock equivalent), and (ii) one warrant to purchase one share of common stock, at a purchase price of $0.06 per unit. The warrants have an exercise price of $0.06 per share, are immediately exercisable, and expire five years following the date of issuance.
Recently Viewed Tickers
With proprietary technology licensed from the University of Mississippi, Emerald is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events .
Emerald Health Therapeutics Inc
Visit a quote page and your recently viewed tickers will be displayed here.
